The proposed study was to develop the preparation of ultrasmall superparamagnetic iron oxide nanoparticles (USPIONs) modified with citric acid, with surface conjugated with lactoferrin (Lf), which used as a potential targeted contrast agent for magnetic resonance imaging (MRI) of brain glioma. USPIONs were prepared by the thermal decomposition method. The hydrophobic USPIONs were coated with citric acid by the ligand exchange method. Then, Lf was conjugated into the surface of USPIONs. The obtained Lf-USPIONs were analyzed by fourier transform infrared (FTIR) spectroscopy and polyacrylamide gel electrophoresis. The size, size distribution, shape and superparamagnetic property of Lf-USPIONs were investigated with TEM and vibrating sample magnetometer (VSM). Both FTIR and electrophoresis analysis demonstrated the successful conjugation of Lf to the surface of USPIONs. The average size of Lf-USPIONs was about 8.4 ± 0.5 nm, which was determined using the statistics of measured over 100 nanoparticles in the TEM image, with a negative charge of −7.3 ± 0.2 mV. TEM imaging revealed that Lf-USPIONs were good in dispersion and polygonal in morphology. VSM results indicated that Lf-USPIONs were superparamagnetic and the saturated magnetic intensity was about 69.8 emu/g. The Lf-USPIONs also showed good biocompatibility in hemolysis, cytotoxicity, cell migration and blood biochemistry studies. MR imaging results in vitro and in vivo indicated that Lf-USPIONs exhibited good negative contrast enhancement. Taken together, Lf-USPIONs hold great potential for brain gliomas MR imaging as a nanosized targeted contrast agent.
KimHRKimSHLeeJI, et al.
Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume. J Neurooncol2015;
121: 311–318.
2.
ChenLHPanCDiplasBH, et al.
The integrated genomic and epigenomic landscape of brainstem glioma. Nat Commun2020;
11: 3077.
3.
de Souza AlbernazMTomaSHClantonJ, et al.
Decorated superparamagnetic iron oxide nanoparticles with monoclonal antibody and diethylene-triamine-pentaacetic acid labeled with thechnetium-99m and galium-68 for breast cancer imaging. Pharm Res2018;
35: 24.
4.
WangDWangCWangL, et al.
A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment. Drug Deliv2019;
26: 551–565.
5.
DenoraNLeeCIacobazziRM, et al.
TSPO-targeted NIR-fluorescent ultra-small iron oxide nanoparticles for glioblastoma imaging. Eur J Pharm Sci2019;
139: 105047.
6.
AramiHPatelCBMadsenSJ, et al.
Nanomedicine for spontaneous brain tumors: a companion clinical trial. ACS Nano2019;
13: 2858–2869.
7.
LiuLLiuLLiY, et al.
Ultrasmall superparamagnetic nanoparticles targeting E-selectin: synthesis and effects in mice in vitro and in vivo. Int J Nanomed2019;
14: 4517–4528.
8.
LiYLiDJianK, et al.
A synergistically enhanced T1 and T(2)-weighted magnetic resonance/near-Infrared contrast agent of Gd-Doping Fe(3)O(4)@fluorescence PEGylated nanoparticles for multimodality imaging of hepatocarcinoma. J Biomed Nanotechnol2019;
15: 85–99.
9.
DuCLiuXHuH, et al.
Dual-targeting and excretable ultrasmall SPIONs for T1-weighted positive MR imaging of intracranial glioblastoma cells by targeting the lipoprotein receptor-related protein. J Mater Chem B2020;
8: 2296–2306.
10.
FuHMiaoCRuiY, et al.
Strategy to prevent cardiac toxicity induced by polyacrylic acid decorated iron MRI contrast agent and investigation of its mechanism. Biomaterials2019;
222: 119442.
11.
MaXWangSHuL, et al.
Imaging characteristics of USPIO nanoparticles (<5 nm) as MR contrast agent in vitro and in the liver of rats. Contrast Media Mol Imaging2019;
2019: 1–9.
12.
FrantellizziVConteMPonticoM, et al.
New frontiers in molecular imaging with superparamagnetic iron oxide nanoparticles (SPIONs): efficacy, toxicity, and future applications. Nucl Med Mol Imaging2020;
54: 65–80.
13.
DuCWangJLiuX, et al.
Construction of pepstatin A-conjugated ultrasmall SPIONs for targeted positive MR imaging of epilepsy-overexpressed P-glycoprotein. Biomaterials2020;
230: 119581.
14.
JiangLZhouQMuK, et al.
pH/temperature sensitive magnetic nanogels conjugated with Cy5.5-labled lactoferrin for MR and fluorescence imaging of glioma in rats. Biomaterials2013;
34: 7418–7428.
15.
JiaGHanYAnY, et al.
NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials2018;
178: 302–316.
16.
MathieuPCoppelYRespaudM, et al.
Silica coated iron/iron oxide nanoparticles as a Nano-Platform for T2 weighted magnetic resonance imaging. Molecules2019;
24: 1–20.
17.
RafieepourAAzariMRPeiroviH, et al.
Investigation of the effect of magnetite iron oxide particles size on cytotoxicity in A549 cell line. Toxicol Ind Health2019;
35: 703–713.
18.
KafrouniLSavadogoO.Recent progress on magnetic nanoparticles for magnetic hyperthermia. Prog Biomater2016;
5: 147–160.
19.
CheeHLGanCRRNgM, et al.
Biocompatible peptide-coated ultrasmall superparamagnetic iron oxide nanoparticles for in vivo contrast-enhanced magnetic resonance imaging. ACS Nano2018;
12: 6480–6491.
20.
TavaresAJPoonWZhangYN, et al.
Effect of removing Kupffer cells on nanoparticle tumor delivery. Proc Natl Acad Sci USA2017;
114: E10871–E10880.
21.
XiongFHuKYuH, et al.
A functional iron oxide nanoparticles modified with PLA-PEG-DG as tumor-targeted MRI contrast agent. Pharm Res2017;
34: 1683–1692.
22.
AvazzadehRVasheghani-FarahaniESoleimaniM, et al.
Synthesis and application of magnetite dextran-spermine nanoparticles in breast cancer hyperthermia. Prog Biomater2017;
6: 75–84.
23.
Arteaga-CardonaFGutiérrez-GarcíaEHidalgo-TobónS, et al.
Cell viability and MRI performance of highly efficient polyol-coated magnetic nanoparticles. J Nanoparticle Res2016;
18: 345–361.
24.
HaddadPSSantosMCde Guzzi CassagoCA, et al.
Synthesis, characterization, and cytotoxicity of glutathione-PEG-iron oxide magnetic nanoparticles. J Nanoparticle Res2016;
18: 369–382.
25.
PrabhaGRajV.Synthesis and characterization of chitosan–polyvinylpyrrolidone–bovine serum albumin-coated magnetic iron oxide nanoparticles as potential carrier for delivery of tamoxifen. J Iran Chem Soc2018;
15: 871–884.
26.
ZhangLTanSLiuY, et al.
In vitro inhibition of tumor growth by low-dose iron oxide nanoparticles activating macrophages. J Biomater Appl2019;
33: 935–945.
27.
ZhangTLiYHongW, et al.
Glucose oxidase and polydopamine functionalized iron oxide nanoparticles: combination of the photothermal effect and reactive oxygen species generation for dual-modality selective cancer therapy. J Mater Chem B2019;
7: 2190–2200.
28.
BellGBalasundaramGAttiaABE, et al.
Functionalised iron oxide nanoparticles for multimodal optoacoustic and magnetic resonance imaging. J Mater Chem B2019;
7: 2212–2219.
29.
AlpsoyLBaykalAKurtanU, et al.
Superparamagnetic iron oxide nanoparticles (SPION) functionalized by caffeic acid (CFA). J Superconductivity Novel Magnet2017;
30: 2699–2706.
30.
LuoBWangSRaoR, et al.
Conjugation magnetic PAEEP-PLLA nanoparticles with lactoferrin as a specific targeting MRI contrast agent for detection of brain glioma in rats. Nanoscale Res Lett2016;
11: 227–238.
31.
BeardRGaboriauDCAGeeAD, et al.
Chemical biology tools for probing transcytosis at the blood-brain barrier. Chem Sci2019;
10: 10772–10778.
32.
ZhangYLvXQuJ, et al.
A systematic strategy for screening therapeutic constituents of schisandra chinensis (turcz.) baill infiltrated blood-brain barrier oriented in lesions using ethanol and water extracts: a novel perspective for exploring chemical material basis of herb medicines. Acta Pharm Sin B2020;
10: 557–568.
33.
NiuXChenJGaoJ.Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: focus on recent advances. Asian J Pharm Sci2019;
14: 480–496.
34.
NiXRZhaoYYCaiHP, et al.
Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models. J Neurooncol2020;
148: 245–258.
35.
KuoYCChenYC.Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles. Int J Pharm2015;
479: 138–149.
36.
ZhaoCZhangJHuH, et al.
Design of lactoferrin modified lipid nano-carriers for efficient brain-targeted delivery of nimodipine. Mater Sci Eng C Mater Biol Appl2018;
92: 1031–1040.
37.
LuTNongZWeiL, et al.
Preparation and anti-cancer activity of transferrin/folic acid double-targeted graphene oxide drug delivery system. J Biomater Appl2020;
35: 15–27.
38.
LuoBLiangHZhangS, et al.
Novel lactoferrin-conjugated amphiphilic poly(aminoethyl ethylene phosphate)/poly(L-lactide) copolymer nanobubbles for tumor-targeting ultrasonic imaging. Int J Nanomedicine2015;
10: 5805–5817.
39.
ZhichuanXShenCHouY, et al.
Oleylamine as both reducing agent and stabilizer in a facile synthesis of magnetite nanoparticles. Chem Mater2009;
21: 1778–1780.
